The adipokine apelin-13 induces expression of prothrombotic tissue factor

Thrombosis and Haemostasis

Volumn 113, Issue 2, 2015, Pages 363-372

  Cirillo, Plinio ^a   Ziviello, Francesca ^a   Pellegrino, Grazia ^b   Conte, Stefano ^b   Cimmino, Giovanni ^b   Giaquinto, Alessandro ^a   Pacifico, Francesco ^a   Leonardi, Antonio ^a   Golino, Paolo ^b   Trimarco, Bruno ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Adipokines; Atherothrombosis; Tissue factor

Indexed keywords

APELIN; APELIN 12; APELIN 13; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; POLYMYXIN B; PROCOAGULANT; PROTHROMBOTIC TISSUE FACTOR; THROMBOPLASTIN; UNCLASSIFIED DRUG; ADIPOCYTOKINE; APELIN-12 PEPTIDE; APELIN-13 PEPTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPROTEIN; SIGNAL PEPTIDE;

ACUTE CORONARY SYNDROME; ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SPECTROPHOTOMETRY; CELL SEPARATION; CORONARY ARTERY THROMBOSIS; CYTOLOGY; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; METABOLISM; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

ADIPOKINES; CELL SEPARATION; CORONARY THROMBOSIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MONOCYTES; NF-KAPPA B; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 84922423971     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-05-0451     Document Type: Article

References (43)

1. Hubert HB, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-977.
2. Berg AH, Scherer PE. Adipose Tissue, Inflammation, and Cardiovascular Disease. Circ Res 2005; 96: 939-994.
3. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003; 115: 37-41.
4. Maresca F, et al. Adipokines, Vascular Wall, and Cardiovascular Disease: A Focused Overview of the Role of Adipokines in the Pathophysiology of Cardiovascular Disease. Angiol 2014; Epub ahead of print.
5. Tatemoto K, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471-476.
6. Masri B, et al. Apelin signalling: a promising pathway from cloning to pharmacology. Cell Signal 2005; 17: 415-426.
7. El Messari S, et al. Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. J Neurochem 2004, 90: 1290-1301.
8. Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther. 2005; 107: 198-211.
9. Malyszko J, et al. Visfatin and apelin, new adipokines, and their relation to endothelial function in patients with chronic heart failure. Adv Med Sci 2008; 53: 32-36.
10. Farkasfalvi K, et al. Direct effects of apelin on cardiomycocite contractility and electrophysiology. Biochem Biophys Res Commun 2007; 357: 889-895.
11. Lu Y, et al. Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF. kB/JNK signal pathway in human umbilical vein endothelial cells. Amino Acids 2012; 43: 2125-2136.
12. Libby P, et al. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
13. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 1986; 314: 488-500.
14. Annex BH, et al. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-622.
15. Pawashe AB, et al. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 1994; 74: 56-63.
16. Ragni M, et al. Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation 1996; 93: 1913-1918.
17. Wilcox JN, et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839-2843.
18. Chen J, et al. Tissue factor-a receptor involved in the control of cellular properties including angiogenesis Thromb Haemost 2001; 86: 334-345.
19. Rao LV, Pendurthi UR. Tissue factor on cells. Blood Coagul Fibrinolysis 1998; 9: 27-35.
20. Cirillo P, et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 2005; 68: 47-55.
21. Masri B, et al. Apelin activates extracellular signal regulated kinases via a PTXsensitive G protein. Biochem Biophys Res Commun 2002; 90: 539-545.
22. Cirillo P, et al. Pro Athero-thrombotic Effects of Leptin in Human Coronary Endothelial Cells. Thromb Haemost 2010, 103: 1065-1075.
23. Cirillo P, et al. The adipokine visfatin induces Tissue Factor expression in human coronary artery endothelial cells. Another piece in the adipokines puzzle. Thromb Res 2012; 130: 403-408.
24. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary artery disease. AHA nutrition committee. Circulation 1998; 97: 2099-2100.
25. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000; 11: 327-332.
26. Calabrò P, et al. Tissue Factor is Induced by Resistin in Human Coronary Artery Endothelial Cells by NF-kB-dependent Pathway. J Vasc Res 2011; 48: 59-66.
27. Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005; 107: 198-211.
28. Liu XY, et al. Apelin-13 increases expression of ATP-binding cassette transported A1 via activating protein kinase C alpha signaling in THP-1 macrophage-derived foam cells. Atherosclerosis 2013; 226: 398-407.
29. Weir RAP, et al. Plasma apelin concentration is depressed following acute myocardial infarction in man. Eur J Heart Fail 2009; 11: 551-558.
30. Kadoglou NPE, et al. Serum levels of apelin and gherlin in patients with acute coronary syndromes and established coronary artery disease-KOZANI STUDY. Transl Res 2010; 155: 238-246.
31. Pitkin Sl, et al. Modulation of the apelin/APJ system in heart failure and atherosclerosis in man. Br J Pharmacol 2010; 160: 1785-1795.
32. Kojima Y, et al. Upregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouse. Cardiovasc Res 2010; 87: 156-165.
33. Li F, et al. Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D. Front Biosci 2008; 13: 3786-3792.
34. Hosoya M, et al. Molecular and functional characteristics of APJ: tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 2000, 275: 21061-21067.
35. Fan X, et al. Structural and functional study of the apelin 13 peptide, an endogenous ligand of HIV-1 coreceptor, APJ Biochemistry 2003, 42: 10163-10168.
36. Lee DK, et al. The fate of internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin. Biochem Biophys Res Commun 2010; 395: 185-189.
37. Pisarenko OI, et al. In vivo reduction of reperfusion injuty to the heart with apelin-12 peptide in rats. Bull Exp Biol Med 2011; 152: 79-82.
38. Golino P, et al. Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits. Am J Physiol Heart Circ Physiol 2000; 278: H1507-1516.
39. Barnes PJ, Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory disease. N Engl J Med 1997; 336: 1066-1071.
40. Oeth P, et al. RegulatMackman Ne tissue factor gene in human monocytic cells. Arteriocler Thromb Vasc Biol 1997; 17: 365-374.
41. Ritchie ME. Nuclear Factor-kB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 1998; 98: 1707-1713.
42. Wilson SH, et al. Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis 2002; 160: 147-153.
43. Zhen EY, et al. Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma. Anal Biochem 2013; 442: 1-9.